How the technology works
The surgeon sits at a console a few feet from the patient and views the operative field in magnified, high-definition three dimensions. Hand and finger movements are scaled and filtered for tremor, then reproduced by instruments that bend and rotate more widely than the human wrist. A trained surgical team remains at the operating table throughout.
- Four arms: one endoscope, three working instruments
- 10x magnified 3D visualisation of nerves, vessels and tissue planes
- Wristed instruments for dissection in the deep pelvis and upper abdomen
- Every instrument movement is initiated by the surgeon — there is no autonomous action
Why it matters in cancer operations
Cancer surgery is judged on the completeness of the resection: clear margins and an adequate lymph node harvest. Stable magnified vision and articulated instruments help in confined spaces such as the pelvis, the hiatus and the retroperitoneum, where preserving nerves and vessels changes function after surgery. Published series report less blood loss and shorter hospital stay than open surgery for several procedures; long-term cancer control is comparable when the same oncological principles are followed.
What stays the same
The operation planned at the multidisciplinary tumour board does not change because it is done robotically. Staging, margins, lymphadenectomy and the need for chemotherapy or radiotherapy follow NCCN and ESMO guidance regardless of the access route. Robotic access is a means of performing the same oncological operation with a smaller wound footprint.
Common questions
- Does a robot perform the surgery?
- No. The system has no autonomy. It reproduces the surgeon's movements in real time and stops the moment the surgeon's hands leave the controls.
- How long does robotic cancer surgery take?
- Most robotic cancer resections take two to five hours depending on the organ, prior surgery and tumour extent. Complex multi-organ or cytoreductive procedures take longer.
- Is robotic surgery available for every cancer?
- No. Suitability depends on tumour size, invasion of adjacent structures, previous surgery and fitness for prolonged pneumoperitoneum. Some patients are safer with an open operation.
This page is general education, reviewed by Dr. Ishaan Allahabadi, MCh Surgical Oncology (Edge Hill, UK) · MS Surgery · MBBS (Accredited by the Royal College of Surgeons of England). It is not a substitute for individual medical advice. Treatment decisions are made after reviewing your imaging and pathology, in a multidisciplinary tumour board.